Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 5 PART I, 1998, Pages 1511-1517

  Pizzichini, Emilio ^b   Pizzichini, Marcia M M ^b   Gibson, Peter ^b   Parameswaran, K ^b   Gleich, Gerald J ^b   Berman, Les ^b   Dolovich, Jerry ^b   Hargreave, Frederick E ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ELASTASE; EOSINOPHIL CATIONIC PROTEIN; FIBRINOGEN; PLACEBO; PREDNISONE;

ADULT; AGED; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DYSPNEA; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; SINGLE BLIND PROCEDURE; SMOKING; SPUTUM ANALYSIS; TREATMENT OUTCOME;

EID: 0031731419     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.5.9804028     Document Type: Article

References (35)

1. Ramsdale, E. H., M. M. Morris, R. S. Roberts, and F. E. Hargreave. 1984. Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax 39:912-918.
2. Pride, N. B. 1988. Bronchial hyperrectivity in smokers. Eur. Respir. J. 1:485-487.
3. Jeffery, P. K. 1996. Bronchial biopsies and airway inflammation. Eur. Respir. J. 9:1583-1587.
4. 1. Am. J. Respir. Crit. Care Med. 155:852-827.
5. Laitinen, A., and L. A. Laitinen. 1991. Cellular infiltrates in asthma and chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143:1159-1160.
6. Saetta, M., A. Di Stefano, P. Maestrelli, G. Turato, M. P. Ruggieri, P. Calcagni, C. E. Mapp, A. Ciacia, and L. M. Fabbri. 1994. Airway eosinophilia in chronic bronchitis during exacerbations. Am. J. Respir. Crit. Care Med. 150:1646-1652.
7. Chanez, P., A. M. Vignola, T. O'Shaugnessy, I. Enander, D. Li, P. K. Jeffery, and J. Bousquet. 1997. Corticosteroid reversibility in COPD is related to features of asthma. Am. J. Respir. Crit. Care Med. 155:1529-1534.
8. Corrigan, C. J., and A. B. Kay. 1991. The role of inflammatory cells in the pathogenesis of asthma and chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143:1165-1168.
9. Barnes, P. J. 1989. Drug therapy: a new approach to treatment of asthma. N. Engl. J. Med. 321:1517-1527.
10. Schayck, C. P., P. M. Grunsven, and P. N. R. Dekhuijzen. 1996. Do patients with COPD benefit from treatment with inhaled corticosteroids? Eur. Respir. J. 9:1969-1972.
11. Callahan, C. M., R. S. Dittus, and B. P. Katz. 1991. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis. Ann. Intern. Med. 114:216-223.
12. Brown, H. M. 1958. Treatment of chronic asthma with prednisolone: significance of eosinophils in the sputum. Lancet 1:1245-1247.
13. Shim, C., C. E. Stover, and M. P. Williams, Jr. 1978. Response to corticosteroids in chronic bronchitis. 1978. J. Allergy Clin. Immunol. 62:363-367.
14. Pizzichini, E., M. M. M. Pizzichini, A. Efthimiadis, S. Evans, M. M. Morris, D. Squillace, G. J. Gleich, J. Dolovich, and F. E. Hargreave. 1996. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid phase measurements. Am. J. Respir. Crit. Care Med. 154:808-817.
15. Pizzichini, M. M. M., E. Pizzichini, L. Clelland, A. Efthimiadis, J. Mahony, J. Dolovich, and F. E. Hargreave. 1997. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am. J. Respir. Crit. Care Med. 155:1501-1508.
16. Guyatt, G. H., L. B. Berman, M. Townsed, S. Pugsley, and L. Chambers. 1987. A measure of quality of life for clinical trials in chronic lung disease. Thorax 42:773-778.
17. American Thoracic Society. 1987. Standardization of spirometry: 1987 update. Am. Rev. Respir. Dis. 136:1285-1298.
18. Crapo, R. O., A. H. Morris, and R. M. Gardner. 1981. Reference spirometric values using techniques and equipment that meets ATS recommendation. Am. Rev. Respir. Dis. 123:659-694.
19. Hunt, L. V., G. J. Gleich, T. Ohnishi, D. A. Weiler, E. S. Mansfield, H. Kita, and S. Sur. 1994. Endotoxin contamination causes neutrophilia following pulmonary antigen challenge. Am. J. Respir. Crit. Care Med. 149:1471-1475.
20. Pizzichini, M. M. M., T. Popov, E. Pizzichini, A. Efthimiadis, P. Hussak, S. Evans, J. Dolovich, and F. E. Hargreave. 1996. Spontaneous and induced sputum compared. Am. J. Respir. Crit. Care Med. 154:866-869.
21. Pizzichini, E., M. M. M. Pizzichini, A. Efthimiadis, J. Dolovich, and F. E. Hargreave. 1997. Measuring airway inflammation in asthma: eosinophils and ECP in induced sputum compared with peripheral blood. J. Allergy Clin. Immunol. 99:539-544.
22. Glantz, S. A., and B. K. Slinker. 1990. Repeated Measures. In S. A. Glantz and B. K. Slinker, editors. Primer of Applied Regression and Analysis of Variance. McGraw-Hill, New York. 381-420.
23. Scadding, J. G. 1983. Definition and clinical categories of asthma. In T. J. H. Clarck, and S. Godfrey, editors. Asthma, 2nd ed. Chapman and Hall, Cambridge, MA. 1-11.
24. Gibson, P. G., F. E. Hargreave, A. Girgis-Gabardo, M. Morris, J. A. Denburg, and J. Dolovich. 1995. Chronic cough with eosinophilic bronchitis and examination for variable airflow obstruction and response to corticosteroid. Clin. Exp. Allergy 25:127-132.
25. Kerstjens, H. A., P. L. Brand, P. H. Quanjer, B. A. van der Bruggen-Bogaarts, G. H. Koeter, and D. S. Postma. 1993. Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airway disease: Dutch CNSLD Study group. Thorax 48:722-729.
26. Elliasson, O., J. Hofmann, D. Trueb, D. Frederick, and J. R. McCormick. 1986. Corticosteroids in COPD: a clinical trial and reassessment of the literature. Chest 89:484-490.
27. Mendella, L. A., J. Manfreda, C. P. W. Warren, and N. R. Anthonisen. 1982. Steroid response in stable chronic obstructive pulmonary disease. Ann. Intern. Med. 96:17-21.
28. James, A. J., K. E. Finucane, G. Ryan, and A. W. Musk. 1988. Bronchial responsiveness, lung mechanics, gas transfer, and corticosteroid response in patients with chronic airflow obstruction. Thorax 43:916-922.
29. Saetta, M., A. Di Stefano, P. Maestrelli, G. Turato, C. E. Mapp, M. Pieno, M. P. Ruggieri, G. Zanguochi, G. Del Prete, and L. M. Fabbri. 1996. Airway eosinophilia and expression of interleukin-5 in asthma and in exacerbations of chronic bronchitis. Clin. Exp. Allergy 26:766-774.
30. Guyatt, G. H., M. Townsend, J. Keller, J. Singer, and S. Nogradi. 1989. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir. Med. 83:293-297.
31. Keatings, V. M., A. Jatakanon, Y. M. Worsdell, and P. J. Barnes. 1997. Effects of inhaled and oral glucocorticosteoids on inflammatory indices in asthma and COPD. Am. J. Respir. Crit. Care Med. 155:542-548.
32. Thompson, A. B., and S. I. Rennard. 1993. Assessment of airways inflammation in chronic bronchitis. Eur. Respir. J. 6:461-464.
33. Keatings, V. M., and P. J. Barnes. 1997. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma and normal subjects. Am. J. Respir. Crit. Care Med. 155:449-453.
34. Pizzichini, M. M. M., E. Pizzichini, A. Efthimiadis, A. J. Chauhan, S. L. Johnston, P. Hussack, J. Mahony, J. Dolovich, and F. E. Hargreave. 1998. Asthma and natural colds: inflammatory indices in induced sputum: a feasibility study. Am. J. Respir. Crit. Care Med. 158:1178-1184.
35. Pepys, J. 1975. Skin test in diagnosis. In P. G. H. Gell, R. R. A. Coombs, and P. J. Lachmann, editors. Clinical Aspects of Immunology, 3rd ed. Blackwell Scientific Publications, Oxford. 55-80.